1 / 11

The Impact of Colorectal Cancer Screening – Initial Results

The Impact of Colorectal Cancer Screening – Initial Results. Mr Michael Proctor, MD Research Fellow, Academic Unit of Surgery, Royal Infirmary, University of Glasgow. The Impact of Colorectal Cancer Screening. Collaboration Glasgow University Department of Surgery, Royal Infirmary

vivek
Download Presentation

The Impact of Colorectal Cancer Screening – Initial Results

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The Impact of Colorectal Cancer Screening – Initial Results Mr Michael Proctor, MD Research Fellow, Academic Unit of Surgery, Royal Infirmary, University of Glasgow.

  2. The Impact of Colorectal Cancer Screening • Collaboration • Glasgow University Department of Surgery, Royal Infirmary • Department of Clinical Pathology, Royal Infirmary • Public Health Screening Unit, Greater Glasgow and Clyde • Aims to investigate the impact on high risk features • Disease stage1 • Tumour pathological characteristics 2 • Host systemic inflammatory response3 • Patients • Greater Glasgow and Clyde Bowel Screening detected cancers (SD) • Glasgow Royal Infirmary non-screen detected cancer cohort (NSD) (1) Dukes , J Path 1932. (2) Petersen et al., Gut 2002. (3) Proctor et al., BJC 2011.

  3. Screen Detected Cancer Stage National Cancer Intelligence Network, 2009.

  4. Patient Characteristics

  5. Tumour Site Right Sided SD - 30% NSD - 40% Left Sided SD - 48% NSD - 24% Rectal SD - 22% NSD - 36%

  6. Tumour and Nodal Stage P <0.001 P=0.414

  7. High Risk Factors

  8. Host Systemic Inflammatory Response

  9. Conclusion • Bowel screening results in improved host and tumour related prognostic factors when compared to a non-screen detected cohort.

  10. Questions?

More Related